1
|
Monzani PS, Sangalli JR, Sampaio RV, Guemra S, Zanin R, Adona PR, Berlingieri MA, Cunha-Filho LFC, Mora-Ocampo IY, Pirovani CP, Meirelles FV, Wheeler MB, Ohashi OM. Human proinsulin production in the milk of transgenic cattle. Biotechnol J 2024; 19:e2300307. [PMID: 38472101 DOI: 10.1002/biot.202300307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 01/16/2024] [Accepted: 01/24/2024] [Indexed: 03/14/2024]
Abstract
BACKGROUND The worldwide growing demand for human insulin for treating diabetes could be supplied by transgenic animals producing insulin in their milk. METHODS AND RESULTS Pseudo-lentivirus containing the bovine β-casein promoter and human insulin sequences was used to produce modified adult fibroblasts, and the cells were used for nuclear transfer. Transgenic embryos were transferred to recipient cows, and one pregnancy was produced. Recombinant protein in milk was evaluated using western blotting and mass spectrometry. One transgenic cow was generated, and in milk analysis, two bands were observed in western blotting with a molecular mass corresponding to the proinsulin and insulin. The mass spectrometry analysis showed the presence of human insulin more than proinsulin in the milk, and it identified proteases in the transgenic milk that could convert proinsulin into insulin and insulin-degrading enzyme that could degrade the recombinant protein. CONCLUSION The methodologies used for generating the transgenic cow allowed the detection of the production of recombinant protein in the milk at low relative expression compared to milk proteins, using mass spectrometry, which was efficient for detecting recombinant protein with low expression in milk. Milk proteases could act on protein processing converting recombinant protein to functional protein. On the other hand, some milk proteases could act in degrading the recombinant protein.
Collapse
Affiliation(s)
- Paulo S Monzani
- Center for Biological and Health Sciences, University of Northern Paraná, Londrina, Paraná, Brazil
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Juliano R Sangalli
- Department of Veterinary Medicine, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Rafael V Sampaio
- Department of Veterinary Medicine, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Samuel Guemra
- Center for Biological and Health Sciences, University of Northern Paraná, Londrina, Paraná, Brazil
| | - Renato Zanin
- Laffranchi Agriculture, Tamarana, Paraná, Brazil
| | - Paulo R Adona
- Center for Biological and Health Sciences, University of Northern Paraná, Londrina, Paraná, Brazil
| | - Maria A Berlingieri
- Center for Biological and Health Sciences, University of Northern Paraná, Londrina, Paraná, Brazil
| | - Luiz F C Cunha-Filho
- Center for Biological and Health Sciences, University of Northern Paraná, Londrina, Paraná, Brazil
| | - Irma Y Mora-Ocampo
- Department of Biological Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, Brazil
| | - Carlos P Pirovani
- Department of Biological Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, Brazil
| | - Flávio V Meirelles
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Matthew B Wheeler
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Otavio M Ohashi
- Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil
| |
Collapse
|
2
|
Gim GM, Jang G. Outlook on genome editing application to cattle. J Vet Sci 2024; 25:e10. [PMID: 38311323 PMCID: PMC10839183 DOI: 10.4142/jvs.23133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 08/04/2023] [Accepted: 08/20/2023] [Indexed: 02/07/2024] Open
Abstract
In livestock industry, there is growing interest in methods to increase the production efficiency of livestock to address food shortages, given the increasing global population. With the advancements in gene engineering technology, it is a valuable tool and has been intensively utilized in research specifically focused on human disease. In historically, this technology has been used with livestock to create human disease models or to produce recombinant proteins from their byproducts. However, in recent years, utilizing gene editing technology, cattle with identified genes related to productivity can be edited, thereby enhancing productivity in response to climate change or specific disease instead of producing recombinant proteins. Furthermore, with the advancement in the efficiency of gene editing, it has become possible to edit multiple genes simultaneously. This cattle breed improvement has been achieved by discovering the genes through the comprehensive analysis of the entire genome of cattle. The cattle industry has been able to address gene bottlenecks that were previously impossible through conventional breeding systems. This review concludes that gene editing is necessary to expand the cattle industry, improving productivity in the future. Additionally, the enhancement of cattle through gene editing is expected to contribute to addressing environmental challenges associated with the cattle industry. Further research and development in gene editing, coupled with genomic analysis technologies, will significantly contribute to solving issues that conventional breeding systems have not been able to address.
Collapse
Affiliation(s)
| | - Goo Jang
- LARTBio Inco, Seoul 06221, Korea
- Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul 08826, Korea
- Comparative medicine Disease Research Center, Seoul National University, Seoul 08826, Korea
- Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya 60115, Indonesia.
| |
Collapse
|
3
|
Kwon DH, Gim GM, Yum SY, Jang G. Current status and future of gene engineering in livestock. BMB Rep 2024; 57:50-59. [PMID: 38053297 PMCID: PMC10828428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 11/23/2023] [Accepted: 12/04/2023] [Indexed: 12/07/2023] Open
Abstract
The application of gene engineering in livestock is necessary for various reasons, such as increasing productivity and producing disease resistance and biomedicine models. Overall, gene engineering provides benefits to the agricultural and research aspects, and humans. In particular, productivity can be increased by producing livestock with enhanced growth and improved feed conversion efficiency. In addition, the application of the disease resistance models prevents the spread of infectious diseases, which reduces the need for treatment, such as the use of antibiotics; consequently, it promotes the overall health of the herd and reduces unexpected economic losses. The application of biomedicine could be a valuable tool for understanding specific livestock diseases and improving human welfare through the development and testing of new vaccines, research on human physiology, such as human metabolism or immune response, and research and development of xenotransplantation models. Gene engineering technology has been evolving, from random, time-consuming, and laborious methods to specific, time-saving, convenient, and stable methods. This paper reviews the overall trend of genetic engineering technologies development and their application for efficient production of genetically engineered livestock, and provides examples of technologies approved by the United States (US) Food and Drug Administration (FDA) for application in humans. [BMB Reports 2024; 57(1): 50-59].
Collapse
Affiliation(s)
- Dong-Hyeok Kwon
- Laboratory of Theriogenology, College of Veterinary Medicine, Research Institute for Veterinary Science, BK21 FOUR Future Veterinary Medicine Leading Education & Research Center, Seoul National University, Seoul 08826, Korea
| | | | | | - Goo Jang
- Laboratory of Theriogenology, College of Veterinary Medicine, Research Institute for Veterinary Science, BK21 FOUR Future Veterinary Medicine Leading Education & Research Center, Seoul National University, Seoul 08826, Korea
- LARTBio Inc., Gwangmyeong 14322, Korea
| |
Collapse
|
4
|
Plotkin LI, Kalajzic I. Animal models for musculoskeletal research. Bone 2023; 173:116813. [PMID: 37244428 PMCID: PMC10513736 DOI: 10.1016/j.bone.2023.116813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Affiliation(s)
- Lilian I Plotkin
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Roudebush Veterans Administration Medical Center, Indiana Center for Musculoskeletal Health, Indianapolis, IN 46202, USA.
| | - Ivo Kalajzic
- Center for Regenerative Medicine and Skeletal Development, UConn Health, Farmington, CT 06032, USA.
| |
Collapse
|
5
|
Monzani PS, Adona PR, Long SA, Wheeler MB. Cows as Bioreactors for the Production of Nutritionally and Biomedically Significant Proteins. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2021; 1354:299-314. [PMID: 34807448 DOI: 10.1007/978-3-030-85686-1_15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Dairy and beef cattle make a vital contribution to global nutrition, and since their domestication, they have been continuously exposed to natural and artificial selection to improve production characteristics. The technologies of transgenesis and gene editing used in cattle are responsible for generating news characteristics in bovine breeding, such as alteration of nutritional components of milk and meat enhancing human health benefits, disease resistance decreasing production costs and offering safe products for human food, as well as the recombinant protein production of biomedical significance. Different methodologies have been used to generate transgenic cattle as bioreactors. These methods include the microinjection of vectors in pronuclear, oocyte or zygote, sperm-mediate transgenesis, and somatic cell nuclear transfer. Gene editing has been applied to eliminate unwanted genes related to human and animal health, such as allergy, infection, or disease, and to insert transgenes into specific sites in the host genome. Methodologies for the generation of genetically modified cattle are laborious and not very efficient. However, in the last 30 years, transgenic animals were produced using many biotechnological tools. The result of these modifications includes (1) the change of nutritional components, including proteins, amino acids and lipids for human nutrition; (2) the removal allergic proteins milk; (3) the production of cows resistant to disease; or (4) the production of essential proteins used in biomedicine (biomedical proteins) in milk and blood plasma. The genetic modification of cattle is a powerful tool for biotechnology. It allows for the generation of new or modified products and functionality that are not currently available in this species.
Collapse
Affiliation(s)
- P S Monzani
- Instituto Chico Mendes de Conservação da Biodiversidade/Centro Nacional de Pesquisa e Conservação da Biodiversidade Aquática Continental, Pirassununga, SP, Brasil.
| | - P R Adona
- Saúde e Produção de Ruminantes, Universidade Norte do Paraná, Arapongas, PR, Brasil
| | - S A Long
- Departments of Animal Sciences and Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA
| | - M B Wheeler
- Departments of Animal Sciences and Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.,Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA
| |
Collapse
|
6
|
Savy V, Alberio V, Vans Landschoot G, Moro LN, Olea FD, Rodríguez-Álvarez L, Salamone DF. Effect of Embryo Aggregation on In Vitro Development of Adipose-Derived Mesenchymal Stem Cell-Derived Bovine Clones. Cell Reprogram 2021; 23:277-289. [PMID: 34648384 DOI: 10.1089/cell.2021.0026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Somatic cell nuclear transfer (SCNT) is a method with unique ability to reprogram the epigenome of a fully differentiated cell. However, its efficiency remains extremely low. In this work, we assessed and combined two simple strategies to improve the SCNT efficiency in the bovine. These are the use of less-differentiated donor cells to facilitate nuclear reprogramming and the embryo aggregation (EA) strategy that is thought to compensate for aberrant epigenome reprogramming. We carefully assessed the optimal time of EA by using in vitro-fertilized (IVF) embryos and evaluated whether the use of adipose-derived mesenchymal stem cells (ASCs) as donor for SCNT together with EA improves the blastocyst rates and quality. Based on our results, we determined that the EA improves the preimplantation embryo development per well of IVF and SCNT embryos. We also demonstrated that day 0 (D0) is the optimal aggregation time that leads to a single blastocyst with uniform distribution of the original blastomeres. This was confirmed in bovine IVF embryos and then, the optimal condition was translated to SCNT embryos. Notably, the relative expression of the trophectoderm (TE) marker KRT18 was significantly different between aggregated and nonaggregated ASC-derived embryos. In the bovine, no effect of the donor cell is observed on the developmental rate, or the embryo quality. Therefore, no synergistic effect of the use of both strategies is observed. Our results suggest that EA at D0 is a simple and accessible strategy that improves the blastocyst rate per well in bovine SCNT and IVF embryos and influence the expression of a TE-related marker. The aggregation of two ASC-derived embryos seems to positively affect the embryo quality, which may improve the postimplantation development.
Collapse
Affiliation(s)
- Virginia Savy
- Laboratorio Biotecnología Animal (LabBA), Dto Producción Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina.,Instituto de Investigaciones en Producción Animal (INPA), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Virgilia Alberio
- Laboratorio Biotecnología Animal (LabBA), Dto Producción Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina.,Instituto de Investigaciones en Producción Animal (INPA), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Geraldina Vans Landschoot
- Laboratorio Biotecnología Animal (LabBA), Dto Producción Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina.,Instituto de Investigaciones en Producción Animal (INPA), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina
| | | | - Fernanda Daniela Olea
- Laboratorio de Medicina Regenerativa Cardiovascular, Instituto de Medicina Traslacional, Trasplante y Bioingeniería (IMETTYB), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Favaloro, Buenos Aires, Argentina
| | - Lleretny Rodríguez-Álvarez
- Department of Animal Science, Faculty of Veterinary Sciences, Universidad de Concepción, Concepción, Chile
| | - Daniel Felipe Salamone
- Laboratorio Biotecnología Animal (LabBA), Dto Producción Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina.,Instituto de Investigaciones en Producción Animal (INPA), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
7
|
Generation of Monogenetic Cattle by Different Techniques of Embryonic Cell and Somatic Cell Cloning – Their Application to Biotechnological, Agricultural, Nutritional, Biomedical and Transgenic Research – A Review. ANNALS OF ANIMAL SCIENCE 2021. [DOI: 10.2478/aoas-2020-0096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Abstract
The development of effective approaches for not only the in vitro maturation (IVM) of heifer/cow oocytes and their extracorporeal fertilization (IVF) but also the non-surgical collection and transfer of bovine embryos has given rise to optimizing comprehensive in vitro embryo production (IVP) technology and improving other assisted reproductive technologies (ART s), such as cattle cloning by embryo bisection, embryonic cell nuclear transfer (ECNT) and somatic cell nuclear transfer (SCNT). The primary goal of the present paper is to demonstrate the progress and achievements in the strategies utilized for embryonic cell cloning and somatic cell cloning in cattle. Moreover, the current article is focused on recognizing and identifying the suitability and reliability of bovine cloning techniques for nutritional biotechnology, agri-food and biopharmaceutical industry, biomedical and transgenic research and for the genetic rescue of endangered or extinct breeds and species of domesticated or wild-living artiodactyl mammals (even-toed ungulates) originating from the family Bovidae.
Collapse
|
8
|
Extranuclear Inheritance of Mitochondrial Genome and Epigenetic Reprogrammability of Chromosomal Telomeres in Somatic Cell Cloning of Mammals. Int J Mol Sci 2021; 22:ijms22063099. [PMID: 33803567 PMCID: PMC8002851 DOI: 10.3390/ijms22063099] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Accepted: 03/16/2021] [Indexed: 12/11/2022] Open
Abstract
The effectiveness of somatic cell nuclear transfer (SCNT) in mammals seems to be still characterized by the disappointingly low rates of cloned embryos, fetuses, and progeny generated. These rates are measured in relation to the numbers of nuclear-transferred oocytes and can vary depending on the technique applied to the reconstruction of enucleated oocytes. The SCNT efficiency is also largely affected by the capability of donor nuclei to be epigenetically reprogrammed in a cytoplasm of reconstructed oocytes. The epigenetic reprogrammability of donor nuclei in SCNT-derived embryos appears to be biased, to a great extent, by the extranuclear (cytoplasmic) inheritance of mitochondrial DNA (mtDNA) fractions originating from donor cells. A high frequency of mtDNA heteroplasmy occurrence can lead to disturbances in the intergenomic crosstalk between mitochondrial and nuclear compartments during the early embryogenesis of SCNT-derived embryos. These disturbances can give rise to incorrect and incomplete epigenetic reprogramming of donor nuclei in mammalian cloned embryos. The dwindling reprogrammability of donor nuclei in the blastomeres of SCNT-derived embryos can also be impacted by impaired epigenetic rearrangements within terminal ends of donor cell-descended chromosomes (i.e., telomeres). Therefore, dysfunctions in epigenetic reprogramming of donor nuclei can contribute to the enhanced attrition of telomeres. This accelerates the processes of epigenomic aging and replicative senescence in the cells forming various tissues and organs of cloned fetuses and progeny. For all the above-mentioned reasons, the current paper aims to overview the state of the art in not only molecular mechanisms underlying intergenomic communication between nuclear and mtDNA molecules in cloned embryos but also intrinsic determinants affecting unfaithful epigenetic reprogrammability of telomeres. The latter is related to their abrasion within somatic cell-inherited chromosomes.
Collapse
|
9
|
Singina GN, Sergiev PV, Lopukhov AV, Rubtsova MP, Taradajnic NP, Ravin NV, Shedova EN, Taradajnic TE, Polejaeva IA, Dozev AV, Brem G, Dontsova OA, Zinovieva NA. Production of a Cloned Offspring and CRISPR/Cas9 Genome Editing of Embryonic Fibroblasts in Cattle. DOKL BIOCHEM BIOPHYS 2021; 496:48-51. [PMID: 33689075 PMCID: PMC7946654 DOI: 10.1134/s1607672921010099] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2020] [Revised: 10/20/2020] [Accepted: 10/21/2020] [Indexed: 11/23/2022]
Abstract
Somatic Cell Nuclear Transfer (SCNT) technique was used to produce the first viable cloned cattle offspring in Russia. Whole-genome SNP genotyping confirmed that the cloned calf was identical to the fibroblast cell line that was used for SCNT. CRISPR/Cas9 approach was subsequently used to knock out genes for beta-lactoglobulin gene (PAEP) and the beta-lactoglobulin-like protein gene (LOC100848610) in the fibroblast cells. Gene editing (GE) efficiency was 4.4% for each of these genes. We successfully obtained single-cell-derived fibroblast colonies containing PAEP and LOC100848610 knockouts, which will be used to produce beta-lactoglobulin-deficient cattle.
Collapse
Affiliation(s)
- G N Singina
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia.
| | - P V Sergiev
- Institute of Functional Genomics, Moscow State University, Moscow, Russia.,Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, Russia.,Faculty of Chemistry, Moscow State University, Moscow, Russia
| | - A V Lopukhov
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| | - M P Rubtsova
- Faculty of Chemistry, Moscow State University, Moscow, Russia
| | - N P Taradajnic
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| | - N V Ravin
- Research Center of Biotechnology, Moscow, Russia
| | - E N Shedova
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| | - T E Taradajnic
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| | - I A Polejaeva
- Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
| | - A V Dozev
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| | - G Brem
- Department of Animal Breeding and Genetics, University of Veterinary Medicine, Vienna, Austria
| | - O A Dontsova
- Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, Russia.,Faculty of Chemistry, Moscow State University, Moscow, Russia.,Belozersky Research Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia.,Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
| | - N A Zinovieva
- Ernst Federal Science Center for Animal Husbandry, Podolsk, Russia
| |
Collapse
|
10
|
Lee SY, Han JH, Lee EK, Kim YK, Hwang SA, Lee SH, Kim M, Cho GY, Hwang JH, Kim SJ, Yoo JG, Cho SK, Lee KJ, Cho WK. Structural and functional characterization of recombinant human growth hormone isolated from transgenic pig milk. PLoS One 2020; 15:e0236788. [PMID: 32735629 PMCID: PMC7394428 DOI: 10.1371/journal.pone.0236788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 07/14/2020] [Indexed: 12/04/2022] Open
Abstract
This study aimed to establish and reproduce transgenic pigs expressing human growth hormone (hGH) in their milk. We also aimed to purify hGH from the milk, to characterize the purified protein, and to assess the potential of our model for mass production of therapeutic proteins using transgenic techniques. Using ~15.5 L transgenic pig milk, we obtained proteins with ≥ 99% purity after three pre-treatments and five column chromatography steps. To confirm the biosimilarity of our milk-derived purified recombinant hGH (CGH942) with commercially available somatropin (Genotropin), we performed spectroscopy, structural, and biological analyses. We observed no difference between the purified protein and Genotropin samples. Furthermore, rat models were used to assess growth promotion potential. Our results indicate that CGH942 promotes growth, by increasing bone development and body weight. Toxicity assessments revealed no abnormal findings after 4 weeks of continuous administration and 2 weeks of recovery. The no-observed-adverse-effect level for both males and females was determined to be 0.6 mg/kg/day. Thus, no toxicological differences were observed between commercially available somatropin and CGH942 obtained from transgenic pig milk. In conclusion, we describe a transgenic technique using pigs, providing a new platform to produce human therapeutic proteins.
Collapse
Affiliation(s)
- So-Young Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- * E-mail:
| | - Joo-Hee Han
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
| | - Eun-Kyeong Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Young Kyu Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Seo-Ah Hwang
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Sung-Hyun Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Maria Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Gye Yoon Cho
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Jae-Ha Hwang
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Su-Jin Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Jae-Gyu Yoo
- Animal Diseases and Biosecurity Team, National Institute of Animal Science, Rural Development Administration, Wanju-gun, Jeollabuk-do, Korea
| | - Seong-Keun Cho
- Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
| | - Kyung-Ju Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Weon-Ki Cho
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| |
Collapse
|
11
|
Disulphide-less crotamine is effective for formation of DNA-peptide complex but is unable to improve bovine embryo transfection. ZYGOTE 2019; 28:72-79. [PMID: 31662126 DOI: 10.1017/s0967199419000716] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
This study aimed to investigate the ability of disulphide-less crotamine (dLCr) to complex DNA and to evaluate whether the DNA-dLCr complex is capable of improving transfection in bovine embryos. Three experiments were performed to: (i) evaluate the formation and stability of the DNA-dLCr complex; (ii) assess the dLCr embryotoxicity by exposure of bovine embryos to dLCr; and (iii) assess the efficiency of bovine embryo transfection after microinjection of the DNA-dLCr complex or green fluorescent protein (GFP) plasmid alone (control). DNA complexation by dLCr after 30 min of incubation at 1:100 and 1:50 proportions presented higher efficiency (P < 0.05) than the two controls: native crotamine (NCr) 1:10 and lipofectamine. There was no difference between DNA-dLCr 1:25 and the controls. The DNA-dLCr complexation was evaluated at different proportions and times. In all, at least half of maximum complexation was achieved within the initial 30 min. No embryotoxicity of dLCr was verified after exposure of in vitro fertilized embryos to different concentrations of the peptide. The effectiveness of dLCr to improve exogenous gene expression was evaluated by microinjection of the DNA-dLCr complex into in vitro fertilized zygotes, followed by verification of both embryo development and GFP expression. From embryos microinjected with DNA only, 4.6% and 2.8% expressed the GFP transgene at day 5 and day 7, respectively. The DNA-dLCr complex did not increase the number of GFP-positive embryos. In conclusion, dLCr forms a complex with DNA and its application in in vitro culture is possible. However, the dLCr peptide sequence should be redesigned to improve GFP expression.
Collapse
|
12
|
Guerrero Montero I, Richards KL, Jawara C, Browning DF, Peswani AR, Labrit M, Allen M, Aubry C, Davé E, Humphreys DP, Busby SJW, Robinson C. Escherichia coli "TatExpress" strains export several g/L human growth hormone to the periplasm by the Tat pathway. Biotechnol Bioeng 2019; 116:3282-3291. [PMID: 31429928 PMCID: PMC6907408 DOI: 10.1002/bit.27147] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Revised: 08/12/2019] [Accepted: 08/13/2019] [Indexed: 12/19/2022]
Abstract
Escherichia coli is a heavily used platform for the production of biotherapeutic and other high‐value proteins, and a favored strategy is to export the protein of interest to the periplasm to simplify downstream processing and facilitate disulfide bond formation. The Sec pathway is the standard means of transporting the target protein but it is unable to transport complex or rapidly folding proteins because the Sec system can only transport proteins in an unfolded state. The Tat system also operates to transport proteins to the periplasm, and it has significant potential as an alternative means of recombinant protein production because it transports fully folded proteins. Here, we have tested the Tat system's full potential for the production of biotherapeutics for the first time using fed‐batch fermentation. We expressed human growth hormone (hGH) with a Tat signal peptide in E. coli W3110 “TatExpress” strains that contain elevated levels of the Tat apparatus. This construct contained four amino acids from TorA at the hGH N‐terminus as well as the initiation methionine from hGH, which is removed in vivo. We show that the protein is efficiently exported to the periplasm during extended fed‐batch fermentation, to the extent that it is by far the most abundant protein in the periplasm. The protein was shown to be homogeneous, disulfide bonded, and active. The bioassay showed that the yields of purified periplasmic hGH are 5.4 g/L culture whereas an enzyme‐linked immunosorbent assay gave a figure of 2.39 g/L. Separate analysis of a TorA signal peptide linked to hGH construct lacking any additional amino acids likewise showed efficient export to the periplasm, although yields were approximately two‐fold lower.
Collapse
Affiliation(s)
| | - Kirsty L Richards
- School of Biosciences, University of Kent, Canterbury, United Kingdom
| | - Chillel Jawara
- School of Biosciences, University of Kent, Canterbury, United Kingdom
| | - Douglas F Browning
- School of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
| | - Amber R Peswani
- School of Biosciences, University of Kent, Canterbury, United Kingdom
| | | | - Matthew Allen
- Discovery Biology, UCB Celltech, Slough, United Kingdom
| | - Cedric Aubry
- Discovery Biology, UCB Celltech, Slough, United Kingdom
| | - Emma Davé
- Discovery Biology, UCB Celltech, Slough, United Kingdom
| | | | - Stephen J W Busby
- School of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
| | - Colin Robinson
- School of Biosciences, University of Kent, Canterbury, United Kingdom
| |
Collapse
|
13
|
Saavedra SL, Martínez Ceron MC, Giudicessi SL, Forno G, Bosco MB, Marani MM, Erra-Balsells R, Albericio F, Cascone O, Camperi SA. Single step recombinant human growth hormone (rhGH) purification from milk by peptide affinity chromatography. Biotechnol Prog 2018; 34:999-1005. [DOI: 10.1002/btpr.2645] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Revised: 02/27/2018] [Indexed: 11/08/2022]
Affiliation(s)
- Soledad L. Saavedra
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956; Buenos Aires 1113 Argentina
- CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956; Buenos Aires 1113 Argentina
| | - María C. Martínez Ceron
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956; Buenos Aires 1113 Argentina
- CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956; Buenos Aires 1113 Argentina
| | - Silvana L. Giudicessi
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956; Buenos Aires 1113 Argentina
- CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956; Buenos Aires 1113 Argentina
| | - Guillermina Forno
- R&D Zelltek S.A., UNL, FBCB, Ciudad Universitaria, Paraje el Pozo, CC 242; Santa Fe Argentina
| | - María Belén Bosco
- R&D Zelltek S.A., UNL, FBCB, Ciudad Universitaria, Paraje el Pozo, CC 242; Santa Fe Argentina
| | - Mariela M. Marani
- IPEEC-CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas; Bvd. Brown 2915, 9120; Puerto Madryn Chubut Argentina
| | - Rosa Erra-Balsells
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Química Orgánica, Pabellón II, 3 P., Ciudad Universitaria; Buenos Aires 1428 Argentina
- CONICET, Universidad de Buenos Aires, Centro de Investigación en Hidratos de Carbono (CIHIDECAR), Facultad de Ciencias Exactas y Naturales, Pabellón II, 3 P. Ciudad Universitaria; Buenos Aires 1428 Argentina
| | - Fernando Albericio
- CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, and Department of Organic Chemistry; University of Barcelona; Barcelona 08028 Spain
- School of Chemistry and Physics; University of KwaZulu-Natal; Durban 4001 South Africa
| | - Osvaldo Cascone
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956; Buenos Aires 1113 Argentina
- CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956; Buenos Aires 1113 Argentina
| | - Silvia A. Camperi
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956; Buenos Aires 1113 Argentina
- CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956; Buenos Aires 1113 Argentina
| |
Collapse
|
14
|
Park MJ, Kim EY, Kang MJ, Lee JB, Jeong CJ, Park SP. Investigation of the Developmental Potential and Developmental Kinetics of Bovine Parthenogenetic and Somatic Cell Nuclear Transfer Embryos Using a Time-Lapse Monitoring System. Cell Reprogram 2017. [DOI: 10.1089/cell.2017.0003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Min-Jee Park
- Jeju National University Stem Cell Research Center, Seoul, Korea
- Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju, Korea
- Mirae Cell Bio, Inc., Seoul, Korea
| | - Eun-Young Kim
- Jeju National University Stem Cell Research Center, Seoul, Korea
- Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju, Korea
- Mirae Cell Bio, Inc., Seoul, Korea
| | - Man-Jong Kang
- College of Agriculture and Life Sciences, Chonnam National University, Gwangju, Korea
| | | | | | - Se-Pill Park
- Jeju National University Stem Cell Research Center, Seoul, Korea
- Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju, Korea
- Mirae Cell Bio, Inc., Seoul, Korea
| |
Collapse
|
15
|
Bevacqua RJ, Fernandez-Martin R, Canel NG, Gibbons A, Texeira D, Lange F, Vans Landschoot G, Savy V, Briski O, Hiriart MI, Grueso E, Ivics Z, Taboga O, Kues WA, Ferraris S, Salamone DF. Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes. PLoS One 2017; 12:e0174025. [PMID: 28301581 PMCID: PMC5354444 DOI: 10.1371/journal.pone.0174025] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2015] [Accepted: 01/06/2017] [Indexed: 12/27/2022] Open
Abstract
Transgenic domestic animals represent an alternative to bioreactors for large-scale production of biopharmaceuticals and could also provide more accurate biomedical models than rodents. However, their generation remains inefficient. Recently, DNA transposons allowed improved transgenesis efficiencies in mice and pigs. In this work, Tn5 and Sleeping Beauty (SB) transposon systems were evaluated for transgenesis by simple cytoplasmic injection in livestock zygotes. In the case of Tn5, the transposome complex of transposon nucleic acid and Tn5 protein was injected. In the case of SB, the supercoiled plasmids encoding a transposon and the SB transposase were co-injected. In vitro produced bovine zygotes were used to establish the cytoplasmic injection conditions. The in vitro cultured blastocysts were evaluated for reporter gene expression and genotyped. Subsequently, both transposon systems were injected in seasonally available ovine zygotes, employing transposons carrying the recombinant human factor IX driven by the beta-lactoglobulin promoter. The Tn5 approach did not result in transgenic lambs. In contrast, the Sleeping Beauty injection resulted in 2 lambs (29%) carrying the transgene. Both animals exhibited cellular mosaicism of the transgene. The extraembryonic tissues (placenta or umbilical cord) of three additional animals were also transgenic. These results show that transpositional transgenesis by cytoplasmic injection of SB transposon components can be applied for the production of transgenic lambs of pharmaceutical interest.
Collapse
Affiliation(s)
- R. J. Bevacqua
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - R. Fernandez-Martin
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - N. G. Canel
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - A. Gibbons
- Experimental Station Bariloche, INTA, Bariloche, Argentina
| | - D. Texeira
- Laboratorio de Fisiologia e Controle da Reprodução, FAVET, UECE, Ceará State, Brasil
| | - F. Lange
- Cloning and Transgenesis Laboratory, Maimónides University, Buenos Aires, Argentina
| | - G. Vans Landschoot
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
- Cloning and Transgenesis Laboratory, Maimónides University, Buenos Aires, Argentina
| | - V. Savy
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - O. Briski
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - M. I. Hiriart
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
| | - E. Grueso
- Paul-Ehrlich-Institute, Langen, Germany
| | - Z. Ivics
- Paul-Ehrlich-Institute, Langen, Germany
| | - O. Taboga
- CICVyA Biotechnology Institute, INTA Castelar, Buenos Aires, Argentina
| | - W. A. Kues
- Friedrich-Loeffler-Institut, Neustadt, Germany
| | - S. Ferraris
- Cloning and Transgenesis Laboratory, Maimónides University, Buenos Aires, Argentina
| | - D. F. Salamone
- Animal Biotechnology Laboratory, Facultad de Agronomia. INPA-CONICET, Buenos Aires University, Buenos Aires, Argentina
- * E-mail:
| |
Collapse
|
16
|
Abbott A. A tale of two governments: the politician behind Argentina's science growth. Nature 2016. [DOI: 10.1038/nature.2016.20414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
17
|
Crotamine, a cell-penetrating peptide, is able to translocate parthenogenetic and in vitro fertilized bovine embryos but does not improve exogenous DNA expression. J Assist Reprod Genet 2016; 33:1405-1413. [PMID: 27515309 DOI: 10.1007/s10815-016-0772-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Accepted: 07/07/2016] [Indexed: 10/21/2022] Open
Abstract
PURPOSE Crotamine is capable of penetrating cells and embryos and transfecting cells with exogenous DNA. However, no studies are available regarding its uptake by parthenogenetic (PA) embryos or its use for transfection in in vitro fertilized (IVF) embryos. This study aimed to determine the translocation kinetics of crotamine into PA and IVF bovine embryos and assess its effect over in vitro development of PA embryos. Moreover, crotamine-DNA complexes were used to test the transfection ability of crotamine in bovine IVF zygotes. METHODS PA and IVF embryos were exposed to labeled crotamine for four interval times. Embryo toxicity was assayed over PA embryos after 24 h of exposure to crotamine. Additionally, IVF embryos were exposed to or injected with a complex formed by crotamine and pCX-EGFP plasmid. RESULTS Confocal images revealed that crotamine was uptaken by PA and IVF embryos as soon as 1 h after exposure. Crotamine exposure did not affect two to eight cells and blastocyst rates or blastocyst cell number (p > 0.05) of PA embryos. Regarding transfection, exposure or injection into the perivitelline space with crotamine-DNA complex did not result in transgene-expressing embryos. Nevertheless, intracytoplasmic injection of plasmid alone showed higher expression rates than did injection with crotamine-DNA complex at days 4 and 7 (p < 0.05). CONCLUSIONS Crotamine is able to translocate through zona pellucida (ZP) of PA and IVF embryos within 1 h of exposure without impairing in vitro development. However, the use of crotamine does not improve exogenous DNA expression in cattle embryos, probably due to the tight complexation of DNA with crotamine.
Collapse
|
18
|
Monzani PS, Adona PR, Ohashi OM, Meirelles FV, Wheeler MB. Transgenic bovine as bioreactors: Challenges and perspectives. Bioengineered 2016; 7:123-31. [PMID: 27166649 DOI: 10.1080/21655979.2016.1171429] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
The use of recombinant proteins has increased in diverse commercial sectors. Various systems for protein production have been used for the optimization of production and functional protein expression. The mammary gland is considered to be a very interesting system for the production of recombinant proteins due to its high level of expression and its ability to perform post-translational modifications. Cows produce large quantities of milk over a long period of lactation, and therefore this species is an important candidate for recombinant protein expression in milk. However, transgenic cows are more difficult to generate due to the inefficiency of transgenic methodologies, the long periods for transgene detection, recombinant protein expression and the fact that only a single calf is obtained at the end of each pregnancy. An increase in efficiency for transgenic methodologies for cattle is a big challenge to overcome. Promising methodologies have been proposed that can help to overcome this obstacle, enabling the use of transgenic cattle as bioreactors for protein production in milk for industry.
Collapse
Affiliation(s)
- Paulo S Monzani
- a Centro de Ciências Biológicas e da Saúde , Universidade Norte do Paraná , Londrina , Paraná , Brazil.,b Departamento de Ciências Básicas , Universidade de São Paulo , Pirassununga , São Paulo , Brazil
| | - Paulo R Adona
- a Centro de Ciências Biológicas e da Saúde , Universidade Norte do Paraná , Londrina , Paraná , Brazil
| | - Otávio M Ohashi
- c Instituto de Ciências Biológicas , Universidade Federal do Pará , Belém , Pará , Brazil
| | - Flávio V Meirelles
- b Departamento de Ciências Básicas , Universidade de São Paulo , Pirassununga , São Paulo , Brazil
| | - Matthew B Wheeler
- d Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign , Urbana , IL , USA
| |
Collapse
|
19
|
Effect of anisomycin, a protein synthesis inhibitor, on the in vitro developmental potential, ploidy and embryo quality of bovine ICSI embryos. ZYGOTE 2016; 24:724-32. [PMID: 27140503 DOI: 10.1017/s0967199416000034] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Increasing the efficiency of intracytoplasmic sperm injection (ICSI) in domestic animals has been attempted by many researchers, however embryonic development to the blastocyst stage remains low compared with that of in vitro fertilization (IVF) embryos. One of the main problems observed in cattle is inadequate oocyte activation after ICSI. The present study compared the effect of cycloheximide (CHX), 6-dimethylaminopurine (DMAP), and anisomycin (ANY) on the fertilization rate, development, ploidy and quality of bovine embryos generated by ICSI. Although no differences were observed between treatments in terms of cleavage, higher blastocyst rates were observed for ANY (37.3%) compared with CHX (21.8%, P 0.05) treatments. No differences were observed in the quality of embryos as assessed by the total number of cells, their distribution to the different embryo compartments [inner cell mass (ICM) and trophectoderm (TE)], the proportion of ICM cells to the total cell numbers and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)-positive cells. Similarly, no differences were observed in the normal ploidy of embryos (56, 67, and 55%) for ANY, CHX and DMAP, respectively. However, higher fertilization rates were observed for ANY (75%) and CHX (87%) treatments compared with DMAP (35%). In conclusion, ANY showed a superior developmental rate compared with CHX treatment. Although no significant differences were observed compared with an improved protocol of DMAP (2Io-DMAP), the lower fertilization rate recorded with DMAP strongly suggests that ANY could be a better alternative for oocyte activation than traditional chemical compounds used currently in ICSI.
Collapse
|
20
|
Mukherjee A, Garrels W, Talluri TR, Tiedemann D, Bősze Z, Ivics Z, Kues WA. Expression of Active Fluorophore Proteins in the Milk of Transgenic Pigs Bypassing the Secretory Pathway. Sci Rep 2016; 6:24464. [PMID: 27086548 PMCID: PMC4834472 DOI: 10.1038/srep24464] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2015] [Accepted: 03/30/2016] [Indexed: 12/12/2022] Open
Abstract
We describe the expression of recombinant fluorescent proteins in the milk of two lines of transgenic pigs generated by Sleeping Beauty transposon-mediated genetic engineering. The Sleeping Beauty transposon consisted of an ubiquitously active CAGGS promoter driving a fluorophore cDNA, encoding either Venus or mCherry. Importantly, the fluorophore cDNAs did not encode for a signal peptide for the secretory pathway, and in previous studies of the transgenic animals a cytoplasmic localization of the fluorophore proteins was found. Unexpectedly, milk samples from lactating sows contained high levels of bioactive Venus or mCherry fluorophores. A detailed analysis suggested that exfoliated cells of the mammary epithelium carried the recombinant proteins passively into the milk. This is the first description of reporter fluorophore expression in the milk of livestock, and the findings may contribute to the development of an alternative concept for the production of bioactive recombinant proteins in the udder.
Collapse
Affiliation(s)
- Ayan Mukherjee
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| | - Wiebke Garrels
- Medical School Hannover, Institute of Laboratory Animal Sciences, Hannover, Germany
| | | | - Daniela Tiedemann
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| | - Zsuzsanna Bősze
- NARIC- Agricultural Biotechnology Institute, Gödöllö, Hungary
| | | | - Wilfried A. Kues
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| |
Collapse
|
21
|
Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? Rev Argent Microbiol 2015; 47:368-79. [PMID: 26654700 DOI: 10.1016/j.ram.2015.09.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2015] [Revised: 09/15/2015] [Accepted: 09/21/2015] [Indexed: 12/30/2022] Open
Abstract
Group A Rotavirus (RVA) remains a leading cause of severe diarrhea and child mortality. The variable domain of camelid heavy chain antibodies (VHH) display potent antigen-binding capacity, have low production costs and are suitable for oral therapies. Two sets of anti-RVA VHHs have been developed: ARP1-ARP3; 2KD1-3B2. Here, we explore the potential of both sets as a prevention strategy complementary to vaccination and a treatment option against RVA-associated diarrhea in endangered populations. Both sets have been expressed in multiple production systems, showing extensive neutralizing capacity against strains of RVA in vitro. They were also tested in the neonatal mouse model with various degrees of success in preventing or treating RVA-induced diarrhea. Interestingly, mitigation of the symptoms was also achieved with freeze-dried ARP1, so that it could be applied in areas where cold chains are difficult to maintain. 3B2 was tested in a pre-clinical trial involving gnotobiotic piglets where it conferred complete protection against RVA-induced diarrhea. ARP1 was used in the first clinical trial for anti-RVA VHHs, successfully reducing stool output in infants with RVA diarrhea, with no detected side effects.
Collapse
|
22
|
Kung M, Lee Y, Hsu J, Huang M, Ju Y. A functional study of proximal goat β-casein promoter and intron 1 in immortalized goat mammary epithelial cells. J Dairy Sci 2015; 98:3859-75. [DOI: 10.3168/jds.2014-9054] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2014] [Accepted: 02/23/2015] [Indexed: 11/19/2022]
|
23
|
Wojtowicz-Krawiec A, Sokolowska I, Smorawinska M, Chojnacka-Puchta L, Mikiewicz D, Lukasiewicz N, Marciniak-Rusek A, Wolinowska R, Bierczynska-Krzysik A, Porebska AJ, Kuthan-Styczen J, Gurba L, Borowicz P, Mazurkiewicz A, Plucienniczak G, Plucienniczak A. Use of Ubp1 protease analog to produce recombinant human growth hormone in Escherichia coli. Microb Cell Fact 2014; 13:113. [PMID: 25158991 PMCID: PMC4154517 DOI: 10.1186/s12934-014-0113-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2014] [Accepted: 07/27/2014] [Indexed: 11/18/2022] Open
Abstract
Background Numerous bacterial human growth hormone (hGH) expression methods under conventional fermentation and induction conditions have been described. Despite significant progress made in this area over the past several years, production of recombinant hGH by using cellular expression systems still requires further optimization. Fusion of the ubiquitin (Ub) tag to the hGH protein allowed to increase of the overall efficiency of the biosynthesis and improve the protein stability. Ub is a protein composed of 76 amino acid residues with a molecular mass of 8.6 kDa, expressed in all eukaryotes. This protein is an element of the universal protein modification system, which does not occur in bacteria, and is a useful carrier for heterologous proteins obtained through expression in Escherichia coli. Purification of Ub-fusion proteins is easier than that of unconjugated recombinant proteins, and Ub can be removed by deubiquitinating proteases (DUBs or UBPs). Results and Conclusion In the present study the UBPD2C protease, a stable UBP1 analog, was produced as a recombinant protein in E. coli and used for production of recombinant human growth hormone (rhGH). hGH was expressed as a fusion protein with Ub as a tag. Our findings show that the UBPD2C protease is very effective in removing the Ub moiety from recombinant Ub-fused hGH. The described approach enables obtaining a considerable yield of rhGH in a purity required for pharmaceutical products.
Collapse
|
24
|
Levarski Z, Šoltýsová A, Krahulec J, Stuchlík S, Turňa J. High-level expression and purification of recombinant human growth hormone produced in soluble form in Escherichia coli. Protein Expr Purif 2014; 100:40-7. [DOI: 10.1016/j.pep.2014.05.003] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Revised: 05/07/2014] [Accepted: 05/12/2014] [Indexed: 11/24/2022]
|
25
|
Batlang U, Tsurupe G, Segwagwe A, Obopile M. Development and application of modern agricultural biotechnology in Botswana: the potentials, opportunities and challenges. GM CROPS & FOOD 2014; 5:183-94. [PMID: 25437237 PMCID: PMC5033224 DOI: 10.4161/21645698.2014.945887] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Revised: 06/10/2014] [Accepted: 06/11/2014] [Indexed: 11/19/2022]
Abstract
In Botswana, approximately 40% of the population live in rural areas and derive most of their livelihood from agriculture by keeping livestock and practising arable farming. Due to the nature of their farming practises livestock and crops are exposed to diseases and environmental stresses. These challenges offer opportunities for application of biotechnology to develop adaptable materials to the country's environment. On the other hand, the perceived risk of genetically modified organisms (GMOs) has dimmed the promise of the technology for its application in agriculture. This calls for a holistic approach to the application of biotechnology to address issues of biosafety of GMOs. We have therefore assessed the potentials, challenges and opportunities to apply biotechnology with specific emphasis on agriculture, taking cognisance of requirement for its research, development and application in research and teaching institutions. In order to achieve this, resource availability, infrastructure, human and laboratory requirements were analyzed. The analysis revealed that the country has the capacity to carry out research in biotechnology in the development and production of genetically modified crops for food and fodder crops. These will include gene discovery, genetic transformation and development of systems to comply with the world regulatory framework on biosafety. In view of the challenges facing the country in agriculture, first generation biotech crops could be released for production. Novel GM products for development may include disease diagnosis kits, animal disease vaccines, and nutrient use efficiency, drought, and pest and disease resistant food and fodder crops.
Collapse
Affiliation(s)
- Utlwang Batlang
- Department of Crop Science and Production; Botswana College of Agriculture; Content Farm; Gaborone, Botswana
| | - Gorata Tsurupe
- Department of Crop Science and Production; Botswana College of Agriculture; Content Farm; Gaborone, Botswana
| | - Amogelang Segwagwe
- Department of Crop Science and Production; Botswana College of Agriculture; Content Farm; Gaborone, Botswana
| | - Motshwari Obopile
- Department of Crop Science and Production; Botswana College of Agriculture; Content Farm; Gaborone, Botswana
| |
Collapse
|
26
|
Batista RITP, Melo CHS, Souza-Fabjan JMG, Teixeira DIA, Melo LM, Freitas VJF. Phenotypic features of first-generation transgenic goats for human granulocyte-colony stimulation factor production in milk. Biotechnol Lett 2014; 36:2155-62. [PMID: 24975728 DOI: 10.1007/s10529-014-1588-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2014] [Accepted: 06/12/2014] [Indexed: 12/20/2022]
Abstract
Human granulocyte-colony stimulating factor (hG-CSF) is a hematopoietic growth factor used in neutropenic patients. It is produced in transgenic bacteria or cultured mammalian cells. As an alternative, we now show that hG-CSF can be expressed in the mammary gland of first-generation (F1) transgenic goats during induced lactation. Despite lower milk production, transgenic females presented a similar milk composition (fat, protein and lactose) when compared to non-transgenic (p > 0.05) ones. The mean concentration (±SD) of recombinant hG-CSF in milk during lactation was 360 ± 178 µg ml(-1). All clinical parameters, as well as kidney and liver function, indicated that F1 transgenic goats were healthy. Additionally, no ectopic hG-CSF expression was detected in studied tissues of F1 transgenic males. Thus, F1 hG-CSF-transgenic goats can express the recombinant protein in milk at quantities compatible with their use as bioreactors in a commercial-scale protein-production program.
Collapse
Affiliation(s)
- Ribrio I T P Batista
- Laboratory of Physiology and Control of Reproduction, Faculty of Veterinary, State University of Ceará, Av. Dr. Silas Munguba, 1700, Fortaleza, CE, 60714-903, Brazil
| | | | | | | | | | | |
Collapse
|
27
|
Murad H, Ali B, Makeya R, Abbady AQ. Prokaryotic overexpression of TEV–rhGH and characterization of its polyclonal antibody. Gene 2014; 542:69-76. [DOI: 10.1016/j.gene.2014.02.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2013] [Revised: 12/12/2013] [Accepted: 02/07/2014] [Indexed: 11/25/2022]
|
28
|
Phosphorylated H2AX in parthenogenetically activated, in vitro fertilized and cloned bovine embryos. ZYGOTE 2014; 23:485-93. [PMID: 24735637 DOI: 10.1017/s0967199414000100] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
In vitro embryo production methods induce DNA damage in the embryos. In response to these injuries, histone H2AX is phosphorylated (γH2AX) and forms foci at the sites of DNA breaks to recruit repair proteins. In this work, we quantified the DNA damage in bovine embryos undergoing parthenogenetic activation (PA), in vitro fertilization (IVF) or somatic cell nuclear transfer (SCNT) by measuring γH2AX accumulation at different developmental stages: 1-cell, 2-cell and blastocyst. At the 1-cell stage, IVF embryos exhibited a greater number of γH2AX foci (606.1 ± 103.2) and greater area of γH2AX staining (12923.6 ± 3214.1) than did PA and SCNT embryos. No differences at the 2-cell stage were observed among embryo types. Although PA, IVF and SCNT were associated with different blastocyst formation rates (31.1%, 19.7% and 8.3%, P < 0.05), no differences in the number of γH2AX foci or area were detected among the treatments. γH2AX is detected in bovine preimplantation embryos produced by PA, IVF and SCNT; the amount of DNA damage was comparable among those embryos developing to the blastocyst stage among different methods for in vitro embryo production. While IVF resulted in increased damage at the 1-cell embryo stage, no difference was observed between PA and SCNT embryos at any developmental stage. The decrease in the number of double-stranded breaks at the blastocyst stage seems to indicate that DNA repair mechanisms are functional during embryo development.
Collapse
|
29
|
|
30
|
Gui T, Liu X, Tao J, Chen J, Li Y, Zhang M, Wu R, Zhang Y, Peng K, Liu Y, Zhang X, Zhang Y. Validation of a recombinant human bactericidal/permeability-increasing protein (hBPI) expression vector using murine mammary gland tumor cells and the early development of hBPI transgenic goat embryos. Anim Reprod Sci 2013; 143:48-56. [PMID: 24289868 DOI: 10.1016/j.anireprosci.2013.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2013] [Revised: 10/22/2013] [Accepted: 10/27/2013] [Indexed: 11/24/2022]
Abstract
Human bactericidal/permeability-increasing protein (hBPI) is the only antibacterial peptide which acts against both gram-negative bacteria and neutralizes endotoxins in human polymorphonuclear neutrophils; therefore, hBPI is of great value in clinical applications. In the study, we constructed a hBPI expression vector (pBC1-Loxp-Neo-Loxp-hBPI) containing the full-length hBPI coding sequence which could be specifically expressed in the mammary gland. To validate the function of the vector, in vitro cultured C127 (mouse mammary Carcinoma Cells) were transfected with the vector, and the transgenic cell clones were selected to express hBPI by hormone induction. The mRNA and protein expression of hBPI showed that the constructed vector was effective and suitable for future application in producing mammary gland bioreactor. Then, female and male goat fibroblasts were transfected with the vector, and two male and two female transgenic clonal cell lines were obtained. Using the transgenic cell lines as nuclear donors for somatic cell nuclear transfer, the reconstructed goat embryos produced from all four clones could develop to blastocysts in vitro. In conclusion, we constructed and validated an efficient mammary gland-specific hBPI expression vector, pBC1-Loxp-Neo-Loxp-hBPI, and transgenic hBPI goat embryos were successfully produced, laying foundations for future production of recombinant hBPI in goat mammary gland.
Collapse
Affiliation(s)
- Tao Gui
- Anhui Provincial Laboratory of Animal Genetic Resources Protection and Breeding, College of Animal Science and Technology, Anhui Agricultural University, No. 130 of Changjiang West Road, Hefei, Anhui Province 230036, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Bevacqua R, Canel N, Hiriart M, Sipowicz P, Rozenblum G, Vitullo A, Radrizzani M, Fernandez Martin R, Salamone D. Simple gene transfer technique based on I-SceI meganuclease and cytoplasmic injection in IVF bovine embryos. Theriogenology 2013; 80:104-13.e1-29. [DOI: 10.1016/j.theriogenology.2013.03.017] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2012] [Revised: 03/08/2013] [Accepted: 03/08/2013] [Indexed: 12/24/2022]
|
32
|
Brisville AC, Fecteau G, Boysen S, Desrochers A, Dorval P, Buczinski S, Lefebvre R, Hélie P, Blondin P, Smith LC. Neonatal morbidity and mortality of 31 calves derived from somatic cloning. J Vet Intern Med 2013; 27:1218-27. [PMID: 23782425 DOI: 10.1111/jvim.12129] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2012] [Revised: 02/22/2013] [Accepted: 05/14/2013] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND The neonatal period is associated with high morbidity and mortality in cloned calves. OBJECTIVE To describe morbidity and mortality in cloned calves from birth to 2 years of age. ANIMALS Thirty-one somatic cell-derived Holstein calves delivered at a veterinary teaching hospital. METHODS Medical files were retrospectively analyzed. RESULTS Four calves were stillborn. Five calves born alive had physical congenital defects. Twenty-three calves had an enlarged umbilical cord. Laboratory abnormalities included acidemia, respiratory acidosis, hyperlactatemia, anemia, stress leukogram, decreased total protein, albumin and globulins, and increased creatinine. Twenty-five calves survived the 1st hour of life. Among them, 11 stood without assistance within 6 hours of birth, 10 calves took longer than 6 hours to stand, and 4 never stood. Twenty-two calves suffered from anorexia. Twelve calves had complications arising from umbilical cord infections. Three calves developed idiopathic hyperthermia (>40°C). Eight calves suffered from gastrointestinal problems, including ruminal distension, abomasal ulcers, neonatal enteritis, intussusception, and abomasal displacement. Mortality between birth and 3 weeks of age was 32% (10/31). Causes of death and reasons for euthanasia included stillbirths, respiratory failure, and limb deformities. Mortality between 3 weeks and 2 years of age was 19% (4/21), with deaths in this group attributed to generalized peritonitis and complications arising from umbilical infections. Overall, mortality rate within 2 years of age was 14/31 (45%). CONCLUSION AND CLINICAL IMPORTANCE Respiratory problems, limb deformities, and umbilical infections were the most common causes of morbidity and mortality in these cloned calves.
Collapse
Affiliation(s)
- A-C Brisville
- Veterinary Hospital Coeur-de-Lotbinière, Laurier-Station, QC, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Novel GM animal technologies and their governance. Transgenic Res 2013; 22:681-95. [DOI: 10.1007/s11248-013-9724-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2013] [Accepted: 06/11/2013] [Indexed: 12/31/2022]
|
34
|
Establishment of a rapid and scalable gene expression system in livestock by site-specific integration. Gene 2013; 515:367-71. [DOI: 10.1016/j.gene.2012.10.017] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Revised: 10/09/2012] [Accepted: 10/15/2012] [Indexed: 02/05/2023]
|
35
|
DNA fragmentation, transgene expression and embryo development after intracytoplasmic injection of DNA-liposome complexes in IVF bovine zygotes. ZYGOTE 2012; 22:195-203. [PMID: 23021149 DOI: 10.1017/s0967199412000433] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Summary This study was designed to evaluate the quality and viability of bovine embryos produced by in vitro fertilization (IVF), after intracytoplasmic injection of pCX-EGFP-liposome complexes or pBCKIP2.8-liposome complexes (plasmids that codify the human insulin gene). Cleavage, blastocysts and expanded blastocysts rates of these both groups were not different from that of controls (IVF or IVF embryos injected with liposomes alone; IVF-L). The percentage of EGFP-positive (EGFP+) blastocysts was 41.8%. In Experiment 2, the blastocysts obtained after injection of pCX-EGFP-liposome complexes that did or did not express the transgene, were analyzed by TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labelling) assay at days 6, 7 and 8 of culture in vitro(Bd6, Bd7 and Bd8), in order to evaluate DNA fragmentation. The EGFP+ blastocysts showed different proportions of TUNEL-positive cells (T+) at Bd6, Bd7 and Bd8 (91, 73.7 and 99.5%, respectively) while blastocysts without EGFP expression (EGFP-) showed statistically lower numbers of fragmented nuclei (0, 44.6 and 85%, respectively; P < 0.05). There was no evidence of DNA fragmentation in either Bd6 or Bd7 IVF and IVF-L control blastocysts, but T+ nuclei were detected at Bd8 in both groups (66.4 and 85.8% respectively). Finally, IVF blastocysts (n = 21) injected with insulin-liposome complexes, cultured for 6, 7 and 8 days, were transferred to recipient cows. Pregnancy rates of 18.2% (2/11) and 40% (2/5) resulted from the transfer of Bd6 and Bd7 cells, respectively. Two pregnancies developed to term but they were not transgenic for the insulin gene. In conclusion, EGFP expression affects DNA integrity but not embryo development. Moreover, additional transfers are required in order to overcome the drawbacks generated by in vitro culture length and transgene expression.
Collapse
|
36
|
Targeted microRNA expression in dairy cattle directs production of β-lactoglobulin-free, high-casein milk. Proc Natl Acad Sci U S A 2012; 109:16811-6. [PMID: 23027958 DOI: 10.1073/pnas.1210057109] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Milk from dairy cows contains the protein β-lactoglobulin (BLG), which is not present in human milk. As it is a major milk allergen, we wished to decrease BLG levels in milk by RNAi. In vitro screening of 10 microRNAs (miRNAs), either individually or in tandem combinations, identified several that achieved as much as a 98% knockdown of BLG. One tandem construct was expressed in the mammary gland of an ovine BLG-expressing mouse model, resulting in 96% knockdown of ovine BLG in milk. Following this in vivo validation, we produced a transgenic calf, engineered to express these tandem miRNAs. Analysis of hormonally induced milk from this calf demonstrated absence of BLG and a concurrent increase of all casein milk proteins. The findings demonstrate miRNA-mediated depletion of an allergenic milk protein in cattle and validate targeted miRNA expression as an effective strategy to alter milk composition and other livestock traits.
Collapse
|
37
|
A bioinformatic evaluation of potential allergenicity of 85 candidate genes in transgenic organisms. CHINESE SCIENCE BULLETIN-CHINESE 2012. [DOI: 10.1007/s11434-012-5149-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Abstract
SummaryOocyte genome cloning is a method by which haploid maternal embryos are obtained in such a way that parthenogenetic haploid blastomeres from these embryos can be considered as a clone of the original gamete. Our objective was to generate oocyte genome replicates and use them to reconstruct biparental embryos by fusion with haploid male hemizygotes. Furthermore, we generated biparental homogeneous transgene-expressing embryos using parthenogenetic haploid blastomeres that expressed a transgene (EGFP). In the first experiment, parthenogenetic haploid embryos were generated by incubation of oocytes in ionomycin and 6-dimethylaminopurine (DMAP) with a 3 h interval to permit their second polar body extrusion. The cleavage rate was 87.3%. To generate transgene-expressing blastomeres, activated oocytes were injected with pCX–EGFP–liposome complexes 3 h post ionomycin exposure, resulting in a cleavage rate of 84.4%. In the second experiment, haploid parthenogenetic blastomeres that were positive or negative for EGFP expression were used to reconstruct biparental embryos. Cleavage and blastocyst rates for the reconstructed embryos were 78.4% and 61.1% and 10.8% and 8.4%, using EGFP-positive or -negative blastomeres, respectively (P < 0.05). All of the reconstructed embryos showed EGFP expression, with 96.6% of them showing homogenic expression. Oct-4 expression in the reconstructed blastocysts displayed a similar pattern as IVF-blastocyst controls. In conclusion, our results proved that it is possible to use oocyte genome replicates to reconstruct biparental bovine embryos and that this technique is efficient to generate homogeneous transgene-expressing embryos.
Collapse
|
39
|
Tan WS, Carlson DF, Walton MW, Fahrenkrug SC, Hackett PB. Precision editing of large animal genomes. ADVANCES IN GENETICS 2012; 80:37-97. [PMID: 23084873 PMCID: PMC3683964 DOI: 10.1016/b978-0-12-404742-6.00002-8] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Transgenic animals are an important source of protein and nutrition for most humans and will play key roles in satisfying the increasing demand for food in an ever-increasing world population. The past decade has experienced a revolution in the development of methods that permit the introduction of specific alterations to complex genomes. This precision will enhance genome-based improvement of farm animals for food production. Precision genetics also will enhance the development of therapeutic biomaterials and models of human disease as resources for the development of advanced patient therapies.
Collapse
Affiliation(s)
- Wenfang Spring Tan
- Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA
| | | | | | | | | |
Collapse
|
40
|
Vichera G, Moro L, Salamone D. Efficient transgene expression in IVF and parthenogenetic bovine embryos by intracytoplasmic injection of DNA-liposome complexes. Reprod Domest Anim 2011; 46:214-20. [PMID: 20565700 DOI: 10.1111/j.1439-0531.2010.01642.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Transgenic animals constitute an important tool with many biotechnological applications. Although there have been advances in this field, we propose a novel method that may greatly increase the efficiency of transgenic animal production and thereby its application. This new technique consists of intracytoplasmic injection of liposomes, in bovine oocytes and zygotes, to introduce exogenous DNA. In the first experiment, we evaluated embryo development and EGFP expression in In Vitro Fertilization (IVF) embryos injected with different concentrations of exogenous DNA-liposome complexes (0.5, 5, 50, 500 ng pCX-EGFP/μl). The highest EGFP-embryos rates were obtained using 500 ng pCX-EGFP/μl. In the second experiment, we evaluated embryo development and EGFP expression following the injection of DNA-liposome complexes into pre-fertilized oocytes and presumptive zygotes, 16 and 24 h post-fertilization. Approximately 70% of the cleaved embryos and 50% of the blastocysts expressed EGFP, when egfp-liposome was injected 16 h post-fertilization. The percentages of positive embryos for the 24-h post-fertilization and pre-fertilization groups were 30.1 and 6.3, respectively. Blastocysts that developed from injected zygotes were analysed by PCR, confirming the presence of transgene in all embryos. Finally, we examined the embryo development and EGFP expression of parthenogenetic embryos that resulted from the injection of egfp-liposome complexes into pre-activated oocytes, and 3 and 11 h post-activated oocytes. The group with the highest expression rate (48.4%) was the one injected 3 h post-activation. In summary, this study reports the efficient, reproducible and fast production of IVF and parthenogenetic embryos expressing EGFP, by the intracytoplasmic injection of liposomes to introduce the foreign DNA.
Collapse
Affiliation(s)
- G Vichera
- Laboratorio de Biotecnología Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina
| | | | | |
Collapse
|
41
|
Cunha NB, Murad AM, Cipriano TM, Araújo ACG, Aragão FJL, Leite A, Vianna GR, McPhee TR, Souza GHMF, Waters MJ, Rech EL. Expression of functional recombinant human growth hormone in transgenic soybean seeds. Transgenic Res 2011; 20:811-26. [PMID: 21069461 DOI: 10.1007/s11248-010-9460-z] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2009] [Accepted: 10/24/2010] [Indexed: 10/18/2022]
Abstract
We produced human growth hormone (hGH), a protein that stimulates growth and cell reproduction, in genetically engineered soybean [Glycine max (L.) Merrill] seeds. Utilising the alpha prime (α') subunit of β-conglycinin tissue-specific promoter from soybean and the α-Coixin signal peptide from Coix lacryma-jobi, we obtained transgenic soybean lines that expressed the mature form of hGH in their seeds. Expression levels of bioactive hGH up to 2.9% of the total soluble seed protein content (corresponding to approximately 9 g kg(-1)) were measured in mature dry soybean seeds. The results of ultrastructural immunocytochemistry assays indicated that the recombinant hGH in seed cotyledonary cells was efficiently directed to protein storage vacuoles. Specific bioassays demonstrated that the hGH expressed in the soybean seeds was fully active. The recombinant hGH protein sequence was confirmed by mass spectrometry characterisation. These results demonstrate that the utilisation of tissue-specific regulatory sequences is an attractive and viable option for achieving high-yield production of recombinant proteins in stable transgenic soybean seeds.
Collapse
Affiliation(s)
- Nicolau B Cunha
- Embrapa Genetic Resources and Biotechnology, Parque Estação Biológica (PqEB), Av. W5 Norte, Brasília, DF, 70770-917, Brazil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Novel methods to induce exogenous gene expression in SCNT, parthenogenic and IVF preimplantation bovine embryos. Transgenic Res 2011; 20:1379-88. [DOI: 10.1007/s11248-011-9503-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2010] [Accepted: 02/18/2011] [Indexed: 10/18/2022]
|
43
|
PEREYRA-BONNET F, GIBBONS A, CUETO M, SIPOWICZ P, FERNÁNDEZ-MARTÍN R, SALAMONE D. Efficiency of Sperm-Mediated Gene Transfer in the Ovine by Laparoscopic Insemination, In Vitro Fertilization and ICSI. J Reprod Dev 2011; 57:188-96. [DOI: 10.1262/jrd.10-063a] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Alejandro GIBBONS
- Laboratorio de Reproducción de Rumiantes Menores, Instituto Nacional de Tecnología Agropecuaria
| | - Marcela CUETO
- Laboratorio de Reproducción de Rumiantes Menores, Instituto Nacional de Tecnología Agropecuaria
| | - Pablo SIPOWICZ
- Laboratorio de Neuro y Citogénetica Molecular, Universidad Nacional de General San Martín
| | | | - Daniel SALAMONE
- Laboratorio de Biotecnología Animal, Facultad de Agronomía, Universidad de Buenos Aires
| |
Collapse
|
44
|
Shadanloo F, Najafi MH, Hosseini SM, Hajian M, Forouzanfar M, Ghaedi K, Abedi P, Ostadhosseini S, Hosseini L, Eskandari-Nasab MP, Esfahani MHN. Sperm status and DNA dose play key roles in sperm/ICSI-mediated gene transfer in caprine. Mol Reprod Dev 2010; 77:868-75. [DOI: 10.1002/mrd.21228] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
45
|
He Z, Zhao Y, Mei G, Li N, Chen Y. Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage? Transgenic Res 2010; 19:519-33. [PMID: 20563642 PMCID: PMC2902731 DOI: 10.1007/s11248-010-9411-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2009] [Accepted: 05/19/2010] [Indexed: 12/03/2022]
Abstract
Animal mammary glands have been successfully employed to produce therapeutic recombinant human proteins. However, considerable variation in animal mammary transgene expression efficiency has been reported. We now consider whether aspects of codon usage and/or protein tertiary structure underlie this variation in mammary transgene expression.
Collapse
Affiliation(s)
- Zuyong He
- State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, 510006, Guangzhou, People's Republic of China
| | | | | | | | | |
Collapse
|
46
|
Vichera G, Alfonso J, Duque CC, Silvestre MA, Pereyra-Bonnet F, Fernández-Martín R, Salamone D. Chemical Activation with a Combination of Ionomycin and Dehydroleucodine for Production of Parthenogenetic, ICSI and Cloned Bovine Embryos. Reprod Domest Anim 2009; 45:e306-12. [DOI: 10.1111/j.1439-0531.2009.01563.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Rabindran S, Stevenson N, Roy G, Fedorkin O, Skarjinskaia M, Ensley B, Yusibov V. Plant-produced human growth hormone shows biological activity in a rat model. Biotechnol Prog 2009; 25:530-4. [PMID: 19301254 DOI: 10.1002/btpr.130] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Plants have been shown to be efficient systems for expressing a wide range of recombinant proteins from various origins. Here, using a plant virus-based expression vector to produce human growth hormone (hGH) in Nicotiana benthamiana plants, we demonstrate, for the first time, that the plant-produced hGH (pphGH) is biologically active in a hypophysectomized rat model. We observed an average weight gain of approximately 17 g per animal in a group of 10 animals that were injected subcutaneously with pphGH with 60 microg/dose for 10 days. With the increasing demand for hGH, accompanied with the need to make this recombinant protein available to a wider population at a more reasonable cost, plants provide a feasible alternative to current production platforms.
Collapse
Affiliation(s)
- Shailaja Rabindran
- Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
| | | | | | | | | | | | | |
Collapse
|
48
|
Bösze Z, Baranyi M, Whitelaw CBA. Producing recombinant human milk proteins in the milk of livestock species. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2008; 606:357-93. [PMID: 18183938 DOI: 10.1007/978-0-387-74087-4_15] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2023]
Abstract
Recombinant human proteins produced by the mammary glands of genetically modified transgenic livestock mammals represent a special aspect of milk bioactive components. For therapeutic applications, the often complex posttranslational modifications of human proteins should be recapitulated in the recombinant products. Compared to alternative production methods, mammary gland production is a viable option, underlined by a number of transgenic livestock animal models producing abundant biologically active foreign proteins in their milk. Recombinant proteins isolated from milk have reached different phases of clinical trials, with the first marketing approval for human therapeutic applications from the EMEA achieved in 2006.
Collapse
|
49
|
Yang BC, Im GS, Kim DH, Yang BS, Oh HJ, Park HS, Seong HH, Kim SW, Ka HH, Lee CK. Development of vitrified–thawed bovine oocytes after in vitro fertilization and somatic cell nuclear transfer. Anim Reprod Sci 2008; 103:25-37. [PMID: 17212979 DOI: 10.1016/j.anireprosci.2006.12.009] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2006] [Revised: 11/28/2006] [Accepted: 12/04/2006] [Indexed: 11/24/2022]
Abstract
Cryopreservation could be a useful technique for providing a steady source of oocytes for nuclear transfer and in vitro embryo production. The purpose of this study was to develop a method for cryopreservation of bovine oocytes while maintaining the developmental potential following subsequent in vitro fertilization (IVF) or somatic cell nuclear transfer (SCNT). Following vitrification-thawing, the surviving oocytes were (a) used for parthenogenetic activation, (b) examined for pronuclear formation after IVF, (c) examined for embryo development after IVF, and (d) used for SCNT employing fetal fibroblasts transfected with green fluorescent protein (GFP) gene. While most of the oocytes survived vitrification when the microdrop method was used (92.50%), the cleavage and blastocyst formation rates after parthenogenetic activation were lower (46.5% and 11.1%) than that in the non-vitrified control (86.6% and 13.5%). After IVF, the pronuclear formation (2PN) of fertilized embryos was lower in the vitrified group than in the control (21.7% and 59.9%). After SCNT, fusion rates were similar in control (58.33%) and vitrified-thawed oocytes (53.19%). However, the cleavage (73.1% and 46.3%) and blastocyst formation rates (22.2%, 7.4%; p<0.05) differed between control and vitrified-thawed oocytes. In vitrified-thawed or control oocytes, all embryos reconstructed using fetal fibroblasts transfected with GFP gene showed GFP expression. To evaluate the complete developmental potential, embryos derived from vitrified-thawed and fresh control oocytes were non-surgically transferred to 27 recipients (16 for control and 11 for vitrified-thawed). In the vitrified-thawed group, two pregnancies were detected at day 60, and one of them lasted until day 222. While in the fresh group, one pregnancy maintained to term. In conclusion, vitrified-thawed bovine oocytes could support development into the subsequent stages after IVF and SCNT. In addition, this study showed the possibility of the vitrified-thawed bovine oocytes in the production of transgenic cloned animals. In addition, further studies are required to increase the efficiency of oocyte vitrification for the practical uses and production of live offspring.
Collapse
Affiliation(s)
- Byoung-Chul Yang
- National Livestock Research Institute, RDA, Suwon 441-706, Republic of Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Pereyra-Bonnet F, Fernández-Martín R, Olivera R, Jarazo J, Vichera G, Gibbons A, Salamone D. A unique method to produce transgenic embryos in ovine, porcine, feline, bovine and equine species. Reprod Fertil Dev 2008; 20:741-9. [DOI: 10.1071/rd07172] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2007] [Accepted: 04/21/2008] [Indexed: 11/23/2022] Open
Abstract
Transgenesis is an essential tool in many biotechnological applications. Intracytoplasmic sperm injection (ICSI)-mediated gene transfer is a powerful technique to obtain transgenic pups; however, most domestic animal embryos do not develop properly after ICSI. An additional step in the protocol, namely assistance by haploid chemical activation, permits the use of ICSI-mediated gene transfer to generate transgenic preimplantation embryos in a wide range of domestic species, including ovine, porcine, feline, equine and bovine. In the present study, spermatozoa from five species were coincubated with pCX-EGFP plasmid and injected into metaphase II oocytes. The chemical activation protocol consisted of ionomycin plus 6-dimethylaminopurine. We detected high proportions of fluorescent EGFP embryos for all five species (23–60%), but with a high frequency of mosaic expression (range 60–85%). To our knowledge, this is the first study to produce exogenous DNA expression in feline and equine embryos. Chemical activation reduces the lag phase of egfp expression in ovine embryos. Our results show that this unique method could be used to obtain ovine, porcine, feline, bovine and equine transgenic preimplantation embryos.
Collapse
|